I-US Food and Drug Administration iphinda ilumkise abathengi malunga neengozi ezinkulu zemveliso esebenzisa i-bleach njengesithako esiphambili kodwa ithengiswa "njengeyeza-zonke."
Ingxelo yabezindaba ye-US Food and Drug Administration (FDA) iphathelele imveliso ebizwa ngokuba yiMiracle Mineral Solution (MMS), ethengiswa kakhulu kwi-intanethi.
Le mveliso inamagama aliqela aquka iMaster Mineral Solution, iMiracle Mineral Supplement, iChlorine Dioxide Protocol, kunye neWater Purification Solution.
Nangona i-FDA ingayivumanga le mveliso, abathengisi bayibhengeza njengeyeza lokulwa neentsholongwane, i-antiviral, kunye ne-antimicrobial.
Nangona kungekho datha yophando lwezonyango, abaxhasi bathi i-MMS inokunyanga ngempumelelo izifo ezahlukeneyo, kuquka umhlaza, i-HIV, i-autism, i-acne, i-malaria, i-influenza, isifo seLyme kunye ne-hepatitis.
Le mveliso lulwelo oluqulethe i-28% ye-sodium chlorite, exutywe ngamanzi aneminerali ngumvelisi. Abathengi kufuneka baxube isisombululo ne-citric acid, njengaleyo ifumaneka kwijusi yelamuni okanye yelayimu.
Lo mxube uxutywa ne-citric acid ukuze uguqulwe ube yi-chlorine dioxide. I-FDA iyichaza njenge-"bleach enamandla." Enyanisweni, iifektri zephepha zihlala zisebenzisa i-chlorine dioxide ukuze zihlambe iphepha, kwaye iinkampani zamanzi nazo zisebenzisa le khemikhali ukucoca amanzi okusela.
I-Arhente yoKhuseleko lweNdalo yase-US (i-EPA) imisela umgangatho ophezulu we-0.8 milligrams (mg) ngelitha, kodwa ithontsi elinye le-MMS liqulethe i-3–8 mg.
Ukusebenzisa ezi mveliso kufana nokusebenzisa i-bleach. Abathengi akufuneki basebenzise ezi mveliso kwaye abazali akufuneki bazinike abantwana babo naphantsi kwayo nayiphi na imeko.
Abantu abathathe i-MMS bafaka iingxelo kwi-FDA. Le ngxelo idwelisa uluhlu olude lweziphumo ebezingalindelekanga, kuquka ukuhlanza okukhulu kunye norhudo, uxinzelelo lwegazi oluphantsi olusongela ubomi, kunye nokungasebenzi kakuhle kwesibindi.
Kuyaphazamisa ukuba abanye abavelisi be-MMS bathi ukuhlanza norhudo ziimpawu ezintle zokuba umxube unokubaphilisa abantu kwizifo zabo.
UGqr. Sharpless uqhube wathi, “I-FDA iza kuqhubeka nokulandela abo bathengisa le mveliso iyingozi kwaye iza kuthatha amanyathelo afanelekileyo okunyanzelisa abo bazama ukuthintela umgaqo we-FDA kwaye bathengise iimveliso ezingavunywanga nezinokuba yingozi kuluntu lwaseMelika.”
"Eyona nto iphambili kuthi kukukhusela uluntu kwiimveliso ezibeka impilo yabo emngciphekweni, kwaye siza kuthumela umyalezo oqinileyo nocacileyo wokuba ezi mveliso zinokubangela ingozi enkulu."
I-MMS ayisiyomveliso intsha, ibisoloko ithengiswa kangangeminyaka engaphezu kweshumi. Ingcali yesayensi uJim Hamble “wayifumanisa” le nto waza wayikhuthaza njengonyango lwe-autism kunye nezinye izifo.
I-US Food and Drug Administration (FDA) ngaphambili ikhuphe ingxelo yabezindaba malunga nale khemikhali. Ingxelo yabezindaba ka-2010 yalumkisa yathi, “Abathengi abathathe i-MMS mabayeke ukuyisebenzisa ngoko nangoko baze bayilahle.”
Ukuqhubela phambili kancinci, ingxelo yabezindaba ka-2015 evela kwi-UK Food Standards Agency (FSA) yalumkisa yathi: “Ukuba isisombululo sincitshiswe ngaphantsi kwento echazwe apha, sinokubangela umonakalo kumathumbu nakwiiseli ezibomvu zegazi kwanokusilela kokuphefumla.” I-FSA ikwacebise abantu abanezi mveliso ukuba “bazilahle.”
I-US Food and Drug Administration (FDA) ithe kwingxelo yayo yamva nje yokuba nabani na “ofumana iziphumo ezibi zempilo emva kokusela le mveliso kufuneka afune unyango ngokukhawuleza.” Le arhente ikwacela abantu ukuba baxele iziganeko ezibi ngenkqubo yolwazi lokhuseleko lwe-FDA ye-MedWatch.
Ukuhlamba nge-bleach kunokunciphisa umngcipheko wosulelo kunye nokudumba kubantu abane-eczema, kodwa iingcali zahlukene ngalo mba. Makhe sixoxe ngophando kunye nendlela...
Isifo seLyme sisifo esidluliselwa ebantwini ziincukuthu ezinemilenze emnyama. Funda ngeempawu, unyango, kunye nendlela yokunciphisa umngcipheko wakho.
Iibhafu zomkhenkce ziya zithandwa kakhulu ngabantu abathanda ukomelela, kodwa ngaba zikhuselekile ngokwenene? Ngaba ziluncedo? Fumanisa ukuba uphando luthini ngeenzuzo zazo.
Ixesha leposi: Meyi-19-2025